Written by the Nuvirox Research Team
Key points
- In a rhinovirus challenge trial, people sleeping under six hours were roughly four times more likely to develop a cold than those sleeping over seven.
- Sleep before and after vaccination tracks with antibody response — but not every study agrees, and one controlled trial found no lasting effect.
- Sleep duration mattered; sleep fragmentation, in that same trial, did not.
Short answer: yes, the effect is real and unusually well demonstrated — with caveats about what kind of sleep loss matters. The strongest evidence comes from experimental viral challenge studies, where researchers measure sleep first and then deliberately expose people to a cold virus, which sidesteps the usual problem that sick people sleep badly. Short sleep predicted infection. But the vaccination literature is messier than the headlines, and the trial evidence does not support every claim made in its name.
Odds of developing a biologically verified cold after rhinovirus exposure, relative to sleeping over seven hours. Adjusted for age and pre-challenge antibody. Data from Prather et al., Sleep, 2015.
How would sleep loss even affect infection risk?
Sleep is when a substantial amount of immune housekeeping happens. Slow-wave sleep is associated with the release of hormones that support adaptive immune processes, and the nocturnal period is when several cytokine rhythms peak. The specific hypothesis in the infection literature is that adequate sleep supports the early adaptive response — the part that decides whether an exposure becomes a symptomatic illness or gets cleared quietly.
That is a mechanism, not a proof. The reason the human data matter so much here is that mechanistic plausibility in immunology is cheap; almost everything is plausible. What moved this field forward was the challenge design.
What human studies actually show
The rhinovirus challenge trial. Prather and colleagues measured sleep with wrist actigraphy for seven consecutive nights in 164 healthy adults aged 18 to 55, then quarantined them and administered nasal drops containing rhinovirus. Over the following five days, participants were monitored for a clinically defined cold — infection plus objective signs of illness. Compared with people sleeping over seven hours, those sleeping under five hours had an odds ratio of 4.50 for developing a cold, and those sleeping five to six hours an odds ratio of 4.24. The association held after adjusting for pre-challenge antibody levels, demographics, season, body mass index, psychological variables, and health practices including smoking.
The honest counterweight inside the same trial. Sleep fragmentation was unrelated to cold susceptibility. Neither were most other sleep variables from the diaries and actigraphy. Duration carried the effect; the quality metrics did not. That is a genuinely useful piece of nuance for anyone who has been told that broken sleep is immunologically equivalent to short sleep — in this dataset it was not.
Vaccination and antibody response. Prather and colleagues also followed 125 healthy midlife adults through the standard three-dose hepatitis B series and found that shorter sleep duration in the natural environment predicted a weaker antibody response. Earlier, Spiegel and colleagues had reported in JAMA that sleep restriction around influenza vaccination roughly halved antibody titres at ten days compared with rested controls.
And the study that did not replicate it. Benedict and colleagues randomised 24 healthy adults to a normal night of sleep or 24 hours of continuous wakefulness around an H1N1 vaccination and followed antibody titres for seven weeks. Acute sleep deprivation had no lasting effect on titre response. The authors of the influenza work had themselves observed that the ten-day difference narrowed by three to four weeks. Taken together, the fair reading is that sleep around vaccination probably influences how quickly protection develops rather than whether it develops at all — and that a single bad night is not the same as chronic short sleep.
Study snapshot — the rhinovirus challenge
| Design | Prospective, experimental viral exposure |
| Participants | 164 healthy adults, aged 18–55 |
| Sleep measure | Wrist actigraphy, 7 consecutive nights before exposure |
| Exposure | Nasal drops containing rhinovirus, then 5-day quarantine |
| Primary finding | Threshold effect at 6 or fewer hours; fragmentation not predictive |
Why the challenge design matters so much
Almost every observational claim about sleep and illness runs into the same problem: being unwell disrupts sleep, so the arrow can point either way. Feeling a cold coming on and sleeping badly that night tells you nothing about causation. We wrote about that specific experience in why your sleep degrades right before you get sick.
The challenge design breaks the loop. Sleep is measured while everyone is healthy; the exposure is identical and controlled; illness is confirmed biologically rather than by self-report. That is why one trial of 164 people carries more weight here than a cohort study of a hundred thousand.
What this does not mean
It does not mean sleep is a shield. Everyone in that trial was exposed to the same dose of virus, and plenty of the short sleepers did not get sick while plenty of the long sleepers did. The effect is a shift in probability across a group, not a guarantee for an individual.
It does not mean one late night will make you ill. The exposure in that study followed a week of measured habitual sleep, not a single short night. The vaccination literature, where single-night deprivation was tested directly, is where the null results cluster.
It also does not mean supplements substitute for sleep. There is a large and mostly disappointing literature on immune-support products, and nothing in the sleep-and-infection work speaks to it. What the work supports is a duration target, not a purchase.
See a doctor if you are getting frequent, severe, or unusually slow-resolving infections. Recurrent infection has a differential diagnosis of its own — including immunodeficiency, poorly controlled diabetes, and medication effects — and attributing it to sleep without a look at the rest is a mistake.
What the numbers suggest about a target
This is the one part of the popular sleep-optimisation stack with a genuinely strong human trial behind it — we sort the rest of that stack in our piece on what sleepmaxxing actually gets right.
The threshold in the challenge data sat at six hours: under six looked meaningfully worse, six to seven was not statistically distinguishable from over seven. That aligns with most consensus recommendations, which land on seven or more hours for adults. It is worth saying plainly that this is a population threshold derived from one well-designed study, not a personalised prescription.
If your sleep is short because you cannot sleep rather than because you will not, the intervention is different — that is insomnia, and the first-line treatment is cognitive behavioural therapy for insomnia, not a longer time-in-bed target. Access to that treatment is its own problem, which we have written about separately.
Frequently asked questions
Does one bad night make me more likely to catch something?
Probably not much. The infection evidence comes from a week of measured habitual sleep, and the study that tested a single night of total sleep deprivation directly — around an H1N1 vaccination — found no lasting effect on antibody response.
Is broken sleep as bad as short sleep for immunity?
In the rhinovirus challenge trial, no. Sleep fragmentation showed no relationship with cold susceptibility, while duration showed a strong one. That is one trial and should not be over-read, but it is the best-controlled data available.
Should I sleep well before a vaccination?
It is a reasonable thing to do and costs nothing. The evidence suggests short sleep is associated with lower antibody responses to influenza and hepatitis B vaccines, though effects appear to narrow over subsequent weeks in at least some studies.
Can catching up on sleep at the weekend undo the effect?
Nobody has tested that in a challenge design, so the honest answer is that we do not know. Recovery sleep restores some measures and not others in other domains, and it would be a stretch to assume infection risk is one of the restorable ones.
Does sleeping more than eight hours help further?
There is no evidence of additional benefit above roughly seven hours in this literature, and long sleep duration has its own complicated associations in epidemiology, largely because illness causes long sleep as often as the reverse.
From Nuvirox
Why we formulated Sleep+ Restore
The finding that matters in this literature is about hours, not products — and we would rather lead with that. Where a formula has a legitimate role is narrower: helping on the nights when you have the time available and still cannot use it.
- A 905 mg blend built around ingredients with actual human trial literature — L-tryptophan and 5-HTP (serotonin and melatonin precursors), L-theanine, GABA, chamomile, passionflower, and ashwagandha.
- 10 mg melatonin per serving. That is a high dose. Most trials showing benefit used 0.5–5 mg, and more is not reliably better — if you are melatonin-naive, start lower and see how you respond.
- St. John’s Wort is in the blend. It has real, documented interactions with hormonal contraceptives, immunosuppressants, biologics, tamoxifen, anticoagulants, and several antidepressants. The 5-HTP carries serotonin-syndrome risk alongside SSRIs, SNRIs, MAOIs, and triptans. Check with a pharmacist before you start.
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should, rather than judging it on two nights.
The bottom line
The link between short sleep and catching colds is one of the better-supported findings in sleep science, because it comes from a design that controls the exposure rather than waiting for life to supply it. Under six hours roughly quadrupled the odds of developing a verified cold after rhinovirus exposure. Fragmentation did not matter in that dataset; duration did. The vaccination evidence points the same direction but less cleanly, with at least one controlled trial finding no lasting effect. The practical takeaway is unglamorous and consistent with everything else in this field: protect the hours.
References
- Prather AA, Janicki-Deverts D, Hall MH, Cohen S. Behaviorally assessed sleep and susceptibility to the common cold. Sleep. 2015;38(9):1353–1359. PMID: 26118561. doi:10.5665/sleep.4968
- Prather AA, Hall M, Fury JM, Ross DC, Muldoon MF, Cohen S, Marsland AL. Sleep and antibody response to hepatitis B vaccination. Sleep. 2012;35(8):1063–1069. PMID: 22851802. PMCID: PMC3397812. doi:10.5665/sleep.1990
- Spiegel K, Sheridan JF, Van Cauter E. Effect of sleep deprivation on response to immunization. JAMA. 2002;288(12):1471–1472. doi:10.1001/jama.288.12.1471-a
- Benedict C, Brytting M, Markström A, Broman JE, Schiöth HB. Acute sleep deprivation has no lasting effects on the human antibody titer response following a novel influenza A H1N1 virus vaccination. BMC Immunol. 2012;13:1. PMID: 22217111. PMCID: PMC3266189. doi:10.1186/1471-2172-13-1
- Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? J Clin Sleep Med. 2017;13(2):351–354. PMID: 27855740. PMCID: PMC5263088. doi:10.5664/jcsm.6472
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.